Objective: Changes in microbiota composition in the distal esophagus may be associated with the pathogenesis of gastroesophageal reflux disease. We aimed to compare the composition of distal esophageal microbiota between Chinese patients with reflux esophagitis (RE) and healthy volunteers using metagenomic high-throughput DNA sequencing and bioinformatic analyses.
| INTRODUCTION
Reflux esophagitis (RE) is an esophageal inflammatory disease caused by the gastric and duodenal contents refluxing into the esophagus. RE can cause symptoms such as heartburn, regurgitation, and a variety of intra-esophageal and extra-esophageal manifestations. Lower esophageal mucosal damage, including esophageal erosion and ulcer, can be observed by endoscopy. [1] [2] [3] The prevalence of RE has been estimated to be 6.4% in Shanghai, China, and only 28.8% of patients with RE suffered from heartburn and/or regurgitation. 4 The esophageal mucosa is a colonization site for microorganisms.
Members of the genus Streptococcus are the major components of normal esophageal microflora. There are also reports on other genera characterizing the esophageal microbiota, such as Prevotella, Veillonella, and Fusobacterium. 5 Recent studies have suggested that changes in the composition of esophageal microbiota may play an important role in the pathogenesis and prognosis of gastroesophageal reflux disease (GERD). 6, 7 In addition to the etiology of esophageal squamous cell carcinoma, with smoking and drinking being the major risk factors, other major esophageal diseases are closely associated with gastroesophageal reflux and reflux-related alterations in the esophageal environment. Reflux also causes changes in the esophageal microecology, leading to persistent and progressive esophageal diseases. [8] [9] [10] However, the detailed changes in microbiota composition in patients with RE, particularly at the population level, are not precisely understood. We therefore aimed to characterize the changes in the distal esophageal microbiota in Chinese patients with RE using metagenomic high-throughput DNA sequencing and bioinformatic analyses.
| MATERIALS AND METHODS

| Selection of participants
Healthy volunteers (controls) recruited by advertisements were selected using the following criteria: no symptoms of heartburn and regurgitation, with a GerdQ questionnaire score <8, a normal esophagus under endoscopy, and normal esophageal squamous epithelium based on the histological examination. Patients from Beijing Anzhen Hospital, Capital Medical University (Beijing, China) who were experiencing heartburn and regurgitation but were not taking any drugs as treatment, were prospectively enrolled from May to October, 2017. The RE patients met the endoscopic criteria of Los Angeles Grade: A, maximum length of mucosal injury <5 mm; B, maximum length of mucosal injury >5 mm but no fusion between injuries; C, mucosal injuries fused with each other but with a fusion <75% of the circumference; and D, injuries fused with each other and the fusion was >75% of the circumference, and the pathologic diagnosis of inflammatory changes to the mucous.
Two distal esophageal (2 cm above the gastroesophageal junction) biopsy specimens were obtained under endoscopy from the patients with RE and the controls. One biopsy specimen was used for histological examination and the other was used for DNA extraction.
Fragments of the 16S ribosomal DNA (16S rDNA) gene were amplified by polymerase chain reaction (PCR) using standard bacterial primers, and the structures of the microbiota were tested. were taking other clinical trials; (h) participants who were unwilling to sign informed consents; (i) patients who had received relevant drugs that could impact on the experimental results within a month prior to the study (e.g., probiotics, proton pump inhibitors or cytokines).
| Ethics
The local Ethics Board of Beijing Anzhen Hospital, Capital Medical University, approved our research (serial number 2017052X). Written informed consent was obtained from each participant.
| Mucosal sample collection and genomic DNA extraction
To avoid cross-contamination the first endoscopic biopsy by the sterile biopsy forceps was used for DNA extraction. After the samples were removed from the esophagus, those intended for DNA extraction were immediately frozen in liquid nitrogen and transported within 6 h to the study center, where they were stored at −80 C until sequencing. Total microbiome DNA was extracted from the esophageal samples using the TIANamp DNA Kit (TianGen Biotech, Beijing, China), following the manufacturer's instructions. 
| Sequencing and bioinformatic analyses
| Real-time PCR
Real-time PCR was performed to verify the results of the highthroughput sequencing, that is, the different abundant bacteria at the phylum and genus level, and the unit of DNA load was copies/μL.
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The PCR kit used was the SYBR FAST qPCR Kit Master Mix (2×) Universal (KAPA Biosystems, Wilmington, MA, USA), following the manufacturer's instructions. The primer sequences of Bacteroidetes,
Prevotella and Moraxella are shown in Table 1 .
| Statistical analysis
Categorical variables were presented as numbers and were compared using the χ 2 test. Continuous variables with normal distributions were expressed as mean ± standard deviation and were compared using independent sample t-test, while those with abnormal distributions, for example, the results of real-time PCR and microbiota structures, were expressed as median and interquartile range (IQR) and were compared using the Mann-Whitney U test. 13,14 A P value < 0.05 was considered statistically significant. All the statistical analyses were performed using SPSS version 22.0 (IBM, Armonk, NY, USA).
3 | RESULTS
| Participants' characteristics and microbiota composition
A total of 17 controls and 32 patients with RE were enrolled. There was no significant difference between the controls and RE group in terms of their age or gender ( Table 2 ). The microbiota findings for the controls and RE group at the phylum level were as follows: Firmicutes 36.9% vs. 37.0% (P = 0.891), Actinobacteria 34.6% vs. 37.8%
(P = 0.240), Bacteroidetes 16.5% vs. 13.3% (P = 0.035), Proteobacteria 10.6% vs. 11.1% (P = 0.204), and others (bacteria less than 2%) 0.5% vs. 0.5% (P = 0.585), respectively. The findings at the class level were: Actinobacteria 33.2% vs. 36.0% (P = 0.275), Clostridia 29.6% vs.
29.7% (P = 0.659), Bacteroidia 16.4% vs. 13.2% (P = 0.034), Gammaproteobacteria 8.7% vs. 9.2% (P = 0.053), Bacilli 6.9% vs. 6.7%
(P = 0.933), and others (bacteria less than 2%) 6.9% vs. 6.7%
(P = 0.355), respectively. The findings for the controls and RE groups at the order level were: Bifidobacteriales 32.5% vs. 35.0% (P = 0.355), Clostridiales 29.6% vs. 29.7% (P = 0.659), Bacteroidales 16.4% vs.
13.2% (P = 0.034), Enterobacteriales 8.0% vs. 8.2% (P = 0.166), Lactobacillales 4.0% vs. 3.7% (P = 0.801), and others 8.6% vs. 8.6%
(P = 0.850), respectively. There were no significant differences at the family and genus levels ( Table 3 ). H. pylori was less commonly found in the RE group than in the control group (15.6% vs. 47.1%, P = 0.018).
In general, at both the phylum and class levels the microbiota composition was similar between the two groups. Firmicutes, Actinobacteria, Bacteroidetes, and Proteobacteria were the four major phyla identified in all samples, accounting for more than 98% of the total population ( Figure 1A ), while the dominant class was Actinobacteria ( Figure 1B ). However, among those four phyla, the abundance of Bacteroidetes was significantly reduced in the RE group (P = 0.035, Mann-Whitney U test; Table 2 ).
| Moderate dysbiosis in the composition of distal esophageal microbiota in patients with RE
There were more species in the controls than in the RE group, that is, 830 OTU vs. 804 OTU on average, although the difference did not achieve statistical significance (P = 0.12, Mann-Whitney U test; Figure 2A ). The Shannon index also reflected this trend, which indicated an α-diversity ( Figure 2B ). The differences in microbiota composition between the two groups were then compared. In both principal coordinate and non-metric multidimensional scaling analyses the two groups were not independently clustered (Figure 3) . However, the microbiota in patients with RE were more divergent than those in controls, as reflected by the more dispersed RE samples. In summary, our results suggested that there was a moderate dysbiosis in the composition of distal esophageal microbiota in patients with RE.
A linear discriminant analysis with effect size was used to identify the different abundant bacteria between the controls and RE group.
At the genus level, Prevotella, Helicobacter, and Moraxella were the three major genera that were obviously less abundant in the patients with RE (linear discriminant analysis score >2.0; Figure 4 ). FIGURE 1 Microbiota structure at (A) phylum and (B) class levels in all participants including healthy controls and patients with reflux esophagitis. Firmicutes, Actinobacteria, Bacteroidetes, and Proteobacteria are the four major phyla identified in all samples, accounting for more than 98% of the total population FIGURE 2 Box plot of (A) operational taxonomic unit (OTU) numbers and (B) the Shannon index in control and reflux esophagitis groups. There were more species in the controls than in the reflux esophagitis group, although the difference did not achieve statistical significance (P = 0.12, Mann-Whitney U test. A, The Shannon index also reflected this trend, indicating an α-diversity FIGURE 3 Differences in microbiota structure between the controls and reflux esophagitis groups (β-diversity) by (A) principal coordinate analysis (PCoA) and (B) non-metric multidimensional scaling (NMDS) analysis. The microbiota in the reflux esophagitis group were more divergent than those in the controls, as reflected by the more dispersed reflux esophagitis samples. PC1, principal coordinate 1; PC2, principal coordinate 2
| Real-time PCR for abundant bacteria
The relative abundance of the three differently abundant genera in the control and reflux esophagitis groups. At the genus level, Prevotella, Helicobacter, and Moraxella were the three major genera and were obviously less abundant in the reflux esophagitis group than in the controls (linear discriminant analysis score >2.0)
Gastroesophageal reflux damages the distal esophageal mucosal barrier, leading to chronic exposure to diverse microbiota and inflammation of the epithelial cells. Inflammation may play a role in the progression from intestinal metaplasia or Barrett's esophagus to esophageal adenocarcinoma. 9 Dysbiosis, which is characterized by the enrichment of some Gram-negative taxa, has been reported to be related to GERD and is hypothesized to lead to Barrett's esophagus and eventually esophageal adenocarcinoma. 5 Fusobacteria was not found in the controls with normal esophagus, but was found in 10% of patients with RE and in 9% of those with Barrett's esophageal mucosa. 6 Moreover, it has been suggested that Fusobacterium nucleatum in esophageal adenocarcinoma tissues is associated with shorter survival through the activation of chemokines and by causing aggressive tumor behavior. 22 Another in vitro model study showed that the expression of tumor necrosis factor-α and p53 was significantly reduced when two different Barrett's esophagus cell lines were co-cultured with Bifidobacterium longum, and the inhibitory effect of probiotics might play a role in preventing the progression of Barrett's esophagus to adenocarcinoma. 23 Our current preliminary investigation (unpublished) showed that the composition of the esophageal mucosal flora of the patients with esophageal squamous cell carcinoma (n = 9) were significantly We found that esophageal mucosa contains many bacteria, and four strains of bacteria were significantly lower in patients with RE (Prevotella, Helicobacter, and Moraxella were reduced at the genus level, and Bacteroidetes was reduced at the phylum level). There was no significant difference between the two groups with respect to other genera. The main bacteria in the distal esophagus belonged to the Firmicutes (36.9% and 37.0% in the control and RE groups, respectively), Actinobacteria (34.6% and 37.8%), Bacteroidetes (16.5% and 13.3%), and Proteobacteria (10.6% and 11.1%) phyla. Bacteroidetes was the only group whose abundance was significantly lower in the RE group.
These results differ from previous reports. Liu et al. 6 reported that species of Proteobacteria (49% of esophageal microbiota) were the most abundant in Japanese controls, followed by Firmicutes (40%), Bacteroidetes (8%), and Actinobacteria (3%); while in patients with RE the values were: Proteobacteria (43%), Firmicutes (33%), Bacteroidetes (10%), Fusobacteria (10%), and Actinobacteria (2%). Importantly, Fusobacteria were found only in patients with RE. The difference might be related to different ethnic or eating habits in Chinese and Japanese populations. Indeed, Chinese participants showed a higher abundance of Actinobacteria (mainly Bifidobacteriales at the order level, Bifidobacteriaceae at the family level, and Bifidobacterium at the genus level) than Japanese participants. The immune-modulating properties of certain Bifidobacteriales strains may protect the host against infection and aberrant inflammatory responses. 24 The protective role of some Bifidobacteriales may explain the lower prevalence of RE in China and needs to be further investigated.
The interaction between the environment of the human body and microbiota determines the composition of human microorganisms, and when that balance is disrupted it can lead to diseases. In humans, mucosal damage (due to surgery or disease) and changes in their biochemical metabolism can lead to the destruction of the esophageal mucosal environment and changes in microbiota, and eventually lead to esophageal disease. For example, various causes of esophageal dilation (such as cardia retardation and esophageal cancer) can lead to changes in the internal environment, resulting in bacterial overgrowth, increased bacterial species, and higher levels of anaerobic bacteria. 15 Changes in the composition of esophageal microorganisms can damage the esophageal mucosal barrier, leading to mucosal inflammation and persistent disease. 9,10 Although we found that the composition of esophageal microbiota differed between controls and patients with RE, we were unable to determine the causal relationship between changes in the microbiota composition and RE. 25 Research has suggested that a high prevalence of Helicobacter pylori (H. pylori) infection in Asians could protect them against GERD. 26 The protective effects of H. pylori infection may be related to its negative effect on the secretion of gastric acid and the production of ghrelin, a hormone in the gastrointestinal tract that stimulates appetite. 27 In a Chinese population-based study, RE was negatively correlated with H. pylori infection. 4 In our study, Helicobacter was obviously less abundant in the distal esophagus of patients with RE. A rapid urease test of biopsy tissue under endoscopy is a simple and rapid method to detect H. pylori infection with better specificity. Meanwhile, the 13 C-urea breath test was added to the patients with negative rapid urease test results to avoid missed diagnoses. In our study the percentage of H. pylori infection in the RE group was significantly lower than that in control group (15.6%
vs. 47.1%, P = 0.018). A recent study found that GERD with H. pylori infection increased esophageal peristalsis, enhanced lower esophageal sphincter pressure, and reduced esophageal acid exposure more than GERD without H. pylori infection. H. pylori infection may thus be a protective factor in GERD. The explanation for the protective effect of H. pylori infection in GERD is that H. pylori infection can stimulate the vagus nerve receptor in the gastric fundus and cardia, and increase serum gastrin secretion, which can enhance lower esophageal sphincter pressure, as well as reduce gastric acid and the reflux of gastric contents, thereby protecting the esophageal mucosa. 28 The sample size of participants in this study may limit the statistical power. However, this research is the first to reveal the composition of distal esophageal microbiota in Chinese patients using metagenomic high-throughput DNA sequencing and bioinformatic analyses. In future studies we will increase the sample size and explore the therapeutic effects of proton pump inhibitors on esophageal microbiota.
| CONCLUSIONS
The composition of the microbiota in the distal esophagus of Chinese patients with RE was moderately different from that of controls. The extent to which these differences are associated with the pathogenesis of RE needs further investigation.
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